Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details)

v3.7.0.1
Commitments and Contingencies (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Business Acquisition, Contingent Consideration      
Contingent consideration $ 47.5   $ 45.1
Purchase obligation 82.7    
Accrued Liabilities      
Business Acquisition, Contingent Consideration      
Contingent consideration 0.3   0.3
Other Noncurrent Liabilities      
Business Acquisition, Contingent Consideration      
Contingent consideration 47.1   $ 44.8
BioReference      
Business Acquisition, Contingent Consideration      
Severance costs $ 3.3 $ 17.2